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Background
Presenting symptoms in patients with Glu89Gln transthyr-
etin (TTR) gene mutation are related to peripheral and
autonomic nervous system damage; nevertheless,
Glu89Gln TTR gene mutation is responsible for early and
severe cardiac involvement (which significantly worsens
the prognosis). Early diagnosis of cardiac involvement in
subjects with TTR gene mutation can significantly affect
patient therapy.
We compared 99mTc-3, 3-diphosphono-1, 2-propano-
dicarboxylic acid (DPD) imaging with electrocardiogra-
phy (ECG), echocardiography, biomarkers dosage
(N-terminal pro–B-type natriuretic peptide (NT-
proBNP) and troponin-I) and magnetic resonance (MR)
imaging with late gadolinium enhancement (LGE) in
order to determine the most sensitive technique in early
detection of cardiac amyloid deposition in subjects with
Glu89Gln TTR gene mutation.
Methods
Seven asymptomatic subjects (3M and 4F; mean age, 42
years) with Glu89Gln TTR gene mutation and normal
interventricular septum (IVS) thickness and NT-proBNP
level underwent three 99mTc-DPD scans (at baseline
and two and four years later) and were followed-up for
5-8 years by clinical examination, ECG, echocardiogra-
phy and cardiac biomarkers dosage. Baseline MR ima-
ging with LGE was also available.
Scintigraphic images were analyzed visually (grade 0,
no abnormal localization of the radiotracer; grade 1,
myocardial radiotracer uptake lower than bone uptake;
and grade 2, myocardial radiotracer uptake higher than
bone uptake) and semiquantitatively.
Results
Three patients showed no myocardial accumulation in
all 99mTc-DPD scans; increased IVS thickness occurring
four years after the last 99mTc-DPD scan was the only
abnormal finding in these patients. In two patients,
99mTc-DPD scan revealed grade 2 radiotracer uptake;
baseline MR imaging showed focal LGE in both patients.
In these patients, mean left ventricle (LV) wall thickness
>12 mm occurred within 3 years; NT-proBNP reached
the current diagnostic level for cardiac amyloidosis in
only one patient, six years after the positive scan. Two
patients had negative baseline 99mTc-DPD scan and
cardiac uptake in the following scans. Increased mean
LV wall thickness was found three years after positive
scintigraphy; NT-proBNP increased later in one patient.
ECG abnormalities appeared some years after a positive
99mTc-DPD scan had occurred.
Conclusion
Cardiac uptake of 99mTc-DPD precede clinical, instru-
mental and laboratory signs of amyloidosis; it may repre-
sent the earliest sign of cardiac amyloidosis development
in subjects with Glu89Gln TTR gene mutation preceding
of some years fulfillment of current diagnostic criteria for
cardiac amyloidosis.
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